Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica L Carpenter

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|December 3, 2020
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular CarcinomaKim A Reiss, Max M Wattenberg, Nevena Damjanov, et al.
The EMBO Journal|February 25, 2022
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistanceJorida Çoku, David M Booth, Jan Skoda, et al.
JCO Precision Oncology|July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerCharu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
JCO Precision Oncology|August 8, 2022
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic AdenocarcinomaWilliam J Chapin, Jacob E Till, Wei-Ting Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
JCO Precision Oncology|June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based TherapyJeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2021
EUS-based Pancreatic Cancer Surveillance in <i>BRCA1/BRCA2/PALB2/ATM</i> Carriers Without a Family History of Pancreatic CancerBryson W Katona, Jessica M Long, Nuzhat A Ahmad, et al.
Prostate Cancer and Prostatic Diseases|October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamideNaomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Science (New York, N.Y.)|June 20, 2024
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patientsDivij Mathew, Melina E Marmarelis, Caitlin Foley, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|December 3, 2020
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular CarcinomaKim A Reiss, Max M Wattenberg, Nevena Damjanov, et al.
The EMBO Journal|February 25, 2022
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistanceJorida Çoku, David M Booth, Jan Skoda, et al.
JCO Precision Oncology|July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerCharu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
JCO Precision Oncology|August 8, 2022
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic AdenocarcinomaWilliam J Chapin, Jacob E Till, Wei-Ting Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
JCO Precision Oncology|June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based TherapyJeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2021
EUS-based Pancreatic Cancer Surveillance in <i>BRCA1/BRCA2/PALB2/ATM</i> Carriers Without a Family History of Pancreatic CancerBryson W Katona, Jessica M Long, Nuzhat A Ahmad, et al.
Prostate Cancer and Prostatic Diseases|October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamideNaomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Science (New York, N.Y.)|June 20, 2024
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patientsDivij Mathew, Melina E Marmarelis, Caitlin Foley, et al.
Pageof 9